A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines

P Ghasemiyeh, S Mohammadi-Samani… - International …, 2021 - Elsevier
20 months has been passed since the detection of the first cases of SARS-CoV-2 infection
named COVID-19 from Wuhan city of China. This novel coronavirus spread rapidly around …

Fast-track development of vaccines for SARS-CoV-2: the shots that saved the world

VP Chavda, Q Yao, LK Vora, V Apostolopoulos… - Frontiers in …, 2022 - frontiersin.org
In December 2019, an outbreak emerged of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) which leads to coronavirus disease 2019 (COVID-19). The World Health …

Efficacy of COVID-19 vaccines: From clinical trials to real life

D Deplanque, O Launay - Therapies, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread around
the globe leading to the COVID-19 pandemic. To mitigate the effects of the virus on public …

COVID-19 vaccines: current and future perspectives

L Soraci, F Lattanzio, G Soraci, ME Gambuzza… - Vaccines, 2022 - mdpi.com
Currently available vaccines against severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) are highly effective but not able to keep the coronavirus disease 2019 …

[图书][B] COVID-19 vaccines: safety surveillance manual

World Health Organization - 2020 - books.google.com
With the early availability of the full sequence of the SARS-COV-2 genome, developing a
vaccine that could help countries to bring citizens' lives back to normal is the highest priority …

Vaccines for COVID-19

JS Tregoning, ES Brown… - Clinical & …, 2020 - academic.oup.com
Since the emergence of COVID-19, caused by the SARS-CoV-2 virus at the end of 2019,
there has been an explosion of vaccine development. By 24 September 2020, a staggering …

The emergence of new strains of SARS-CoV-2. What does it mean for COVID-19 vaccines?

MK Hossain, M Hassanzadeganroudsari… - Expert review of …, 2021 - Taylor & Francis
A novel strain of coronavirus, SARS-CoV-2, the causative agent of coronavirus disease
(COVID-19) was first associated with severe acute respiratory disease in late 2019 and has …

Tracking the COVID-19 vaccines: The global landscape

T Yadav, S Kumar, G Mishra… - Human vaccines & …, 2023 - Taylor & Francis
ABSTRACT COVID-19, a respiratory infectious disease, occurs due to Severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2). Millions of individuals around the world …

Status report on COVID-19 vaccines development

A Kumar, WE Dowling, RG Román… - Current Infectious …, 2021 - Springer
Abstract Purpose of Review The emergence of the severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) has affected lives of billions of individuals, globally. There is …

[HTML][HTML] The race to a COVID-19 vaccine: Opportunities and challenges in development and distribution

RM Burgos, ME Badowski, E Drwiega… - Drugs in …, 2021 - ncbi.nlm.nih.gov
The unprecedented toll of severe acute respiratory syndrome coronavirus 2, the virus
responsible for coronavirus 2019 disease (COVID-19), jumpstarted the race towards the …